Cargando…
Steroid hormone analysis in diagnosis and treatment of DSD: position paper of EU COST Action BM 1303 ‘DSDnet’
Disorders or differences in sex development (DSD) comprise a heterogeneous group of conditions with an atypical sex development. For optimal diagnosis, highly specialised laboratory analyses are required across European countries. Working group 3 of EU COST (European Cooperation in Science and Techn...
Autores principales: | Kulle, A, Krone, N, Holterhus, P M, Schuler, G, Greaves, R F, Juul, A, de Rijke, Y B, Hartmann, M F, Saba, A, Hiort, O, Wudy, S A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5425933/ https://www.ncbi.nlm.nih.gov/pubmed/28188242 http://dx.doi.org/10.1530/EJE-16-0953 |
Ejemplares similares
-
GENETICS IN ENDOCRINOLOGY: Approaches to molecular genetic diagnosis in the management of differences/disorders of sex development (DSD): position paper of EU COST Action BM 1303 ‘DSDnet’
por: Audí, L, et al.
Publicado: (2018) -
Evaluation of DSD training schools organized by cost action BM1303 “DSDnet”
por: Bertalan, R., et al.
Publicado: (2018) -
Position statement: The need for EU legislation to require disclosure and labelling of the composition of medical devices
por: Herman, A., et al.
Publicado: (2021) -
GH safety workshop position paper: a critical appraisal of recombinant human GH therapy in children and adults
por: Allen, D B, et al.
Publicado: (2015) -
Diagnosis and Management Considerations in Steroid-Related Hyperglycemia in COVID-19: A Position Statement from the Endocrine Society of India
por: Das, Sambit, et al.
Publicado: (2021)